{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:05:20Z","timestamp":1765908320260,"version":"3.48.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T00:00:00Z","timestamp":1756857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04411-8","type":"journal-article","created":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T18:46:40Z","timestamp":1756925200000},"page":"1509-1517","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes and treatment adequacy assessment in congenital adrenal hyperplasia: A Single-Center experience with Long-Term Follow-Up"],"prefix":"10.1007","volume":"90","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5782-3743","authenticated-orcid":false,"given":"Neslihan Koray","family":"Fedai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilknur Ozturk","family":"Unsal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sema","family":"Hepsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bekir","family":"Ucan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustafa","family":"Ozbek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erman","family":"Cakal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,3]]},"reference":[{"issue":"1","key":"4411_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1210\/endrev\/bnab016","volume":"43","author":"C Grinten","year":"2022","unstructured":"C.-. Grinten, Congenital adrenal Hyperplasia-Current insights in pathophysiology, diagnostics, and management. Endocr. Rev. 43(1), 91\u2013159 (2022)","journal-title":"Endocr. Rev."},{"issue":"10372","key":"4411_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"M.K. Auer et al., Congenital adrenal hyperplasia. Lancet. 401(10372), 227\u2013244 (2023)","journal-title":"Lancet"},{"issue":"3","key":"4411_CR3","doi-asserted-by":"publisher","first-page":"R125","DOI":"10.1530\/EJE-18-0279","volume":"179","author":"WL Miller","year":"2018","unstructured":"W.L. Miller, MECHANISMS IN ENDOCRINOLOGY: rare defects in adrenal steroidogenesis. Eur. J. Endocrinol. 179(3), R125\u2013R141 (2018)","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"4411_CR4","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"P.W. Speiser et al., Congenital adrenal hyperplasia due to steroid 21-Hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 103(11), 4043\u20134088 (2018)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"13","key":"4411_CR5","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"D.P. Merke, R.J. Auchus, Congenital adrenal hyperplasia due to 21-Hydroxylase deficiency. N Engl. J. Med. 383(13), 1248\u20131261 (2020)","journal-title":"N Engl. J. Med."},{"issue":"1","key":"4411_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.ecl.2020.10.008","volume":"50","author":"S Jha","year":"2021","unstructured":"S. Jha, A.F. Turcu, Nonclassic congenital adrenal hyperplasia: what do endocrinologists need to know?? Endocrinol. Metab. Clin. North. Am. 50(1), 151\u2013165 (2021)","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"1","key":"4411_CR7","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s11154-022-09770-5","volume":"24","author":"JY Maher","year":"2023","unstructured":"J.Y. Maher, V. Gomez-Lobo, D.P. Merke, The management of congenital adrenal hyperplasia during preconception, pregnancy, and postpartum. Rev. Endocr. Metab. Disord. 24(1), 71\u201383 (2023)","journal-title":"Rev. Endocr. Metab. Disord"},{"issue":"3","key":"4411_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/cen.14842","volume":"98","author":"C Carriere","year":"2023","unstructured":"C. Carriere et al., Fertility and pregnancy outcomes in women with nonclassic 21-hydroxylase deficiency. Clin. Endocrinol. (Oxf). 98(3), 315\u2013322 (2023)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"5","key":"4411_CR9","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1210\/jc.2008-1414","volume":"94","author":"N Reisch","year":"2009","unstructured":"N. Reisch et al., High prevalence of reduced fecundity in men with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 94(5), 1665\u20131670 (2009)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"4411_CR10","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1210\/jc.2012-2102","volume":"97","author":"GP Finkielstain","year":"2012","unstructured":"G.P. Finkielstain et al., Clinical characteristics of a cohort of 244 patients with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 97(12), 4429\u20134438 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"4411_CR11","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar et al., Increased cardiovascular and metabolic morbidity in patients with 21-Hydroxylase deficiency: A Swedish Population-Based National cohort study. J. Clin. Endocrinol. Metab. 100(9), 3520\u20133528 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Supplement1","key":"4411_CR12","first-page":"S27","volume":"48","author":"ADAPP Committee","year":"2024","unstructured":"A.D.A.P.P. Committee, 2. Diagnosis and classification of diabetes: standards of care in Diabetes\u20142025. Diabetes Care. 48(Supplement1), S27\u2013S49 (2024)","journal-title":"Diabetes Care"},{"key":"4411_CR13","doi-asserted-by":"crossref","unstructured":"Jellinger, P.S., et al., American Association of Clinical Endocrinologists\u2019 Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: Executive Summary. Endocrine Practice, 2012. 18(2): pp. 269\u2013293","DOI":"10.4158\/EP.18.2.269"},{"issue":"38","key":"4411_CR14","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","volume":"45","author":"JW McEvoy","year":"2024","unstructured":"J.W. McEvoy et al., 2024 ESC guidelines for the management of elevated blood pressure and hypertension. Eur. Heart J. 45(38), 3912\u20134018 (2024)","journal-title":"Eur. Heart J."},{"issue":"6","key":"4411_CR15","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1159\/000333696","volume":"76","author":"TM Volkl","year":"2011","unstructured":"T.M. Volkl et al., Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Horm. Res. Paediatr. 76(6), 400\u2013410 (2011)","journal-title":"Horm. Res. Paediatr."},{"issue":"1","key":"4411_CR16","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.fertnstert.2018.11.037","volume":"111","author":"LG Gomes","year":"2019","unstructured":"L.G. Gomes, T. Bachega, B.B. Mendonca, Classic congenital adrenal hyperplasia and its impact on reproduction. Fertil. Steril. 111(1), 7\u201312 (2019)","journal-title":"Fertil. Steril."},{"issue":"1","key":"4411_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","volume":"50","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, A. Nordenstrom, Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome. Endocrine. 50(1), 32\u201350 (2015)","journal-title":"Endocrine"},{"issue":"2","key":"4411_CR18","doi-asserted-by":"publisher","first-page":"e957","DOI":"10.1210\/clinem\/dgaa801","volume":"106","author":"AL Hirschberg","year":"2021","unstructured":"A.L. Hirschberg et al., Reproductive and perinatal outcomes in women with congenital adrenal hyperplasia: A Population-based cohort study. J. Clin. Endocrinol. Metab. 106(2), e957\u2013e965 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4411_CR19","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1016\/j.rbmo.2020.08.036","volume":"41","author":"A Badeghiesh","year":"2020","unstructured":"A. Badeghiesh et al., Pregnancy, delivery and neonatal outcomes among women with congenital adrenal hyperplasia: a study of a large US database. Reprod. Biomed. Online. 41(6), 1093\u20131099 (2020)","journal-title":"Reprod. Biomed. Online"},{"issue":"3","key":"4411_CR20","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/EJE-20-1093","volume":"184","author":"C Grinten","year":"2021","unstructured":"C.-. Grinten, MANAGEMENT OF ENDOCRINE DISEASE: gonadal dysfunction in congenital adrenal hyperplasia. Eur. J. Endocrinol. 184(3), R85\u2013R97 (2021)","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"4411_CR21","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1210\/jc.2006-1757","volume":"92","author":"F Gastaud","year":"2007","unstructured":"F. Gastaud et al., Impaired sexual and reproductive outcomes in women with classical forms of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 92(4), 1391\u20131396 (2007)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"4411_CR22","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/j.1365-2265.2009.03563.x","volume":"70","author":"A Casteras","year":"2009","unstructured":"A. Casteras et al., Reassessing fecundity in women with classical congenital adrenal hyperplasia (CAH): normal pregnancy rate but reduced fertility rate. Clin. Endocrinol. (Oxf). 70(6), 833\u2013837 (2009)","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"1","key":"4411_CR23","doi-asserted-by":"publisher","first-page":"bvae211","DOI":"10.1210\/jendso\/bvae211","volume":"9","author":"MK Auer","year":"2024","unstructured":"M.K. Auer et al., Women with congenital adrenal hyperplasia have favorable pregnancy outcomes but prolonged time to conceive. J. Endocr. Soc. 9(1), bvae211 (2024)","journal-title":"J. Endocr. Soc."},{"issue":"12","key":"4411_CR24","first-page":"e5247","volume":"106","author":"A Torky","year":"2021","unstructured":"A. Torky et al., Cardiovascular disease risk factors and metabolic morbidity in a longitudinal study of congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. 106(12), e5247\u2013e5257 (2021)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"4411_CR25","doi-asserted-by":"publisher","first-page":"105540","DOI":"10.1016\/j.jsbmb.2019.105540","volume":"197","author":"L Paizoni","year":"2020","unstructured":"L. Paizoni et al., Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Steroid Biochem. Mol. Biol. 197, 105540 (2020)","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"6","key":"4411_CR26","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1210\/js.2019-00136","volume":"3","author":"E Whittle","year":"2019","unstructured":"E. Whittle, H. Falhammar, Glucocorticoid regimens in the treatment of congenital adrenal hyperplasia: A systematic review and Meta-Analysis. J. Endocr. Soc. 3(6), 1227\u20131245 (2019)","journal-title":"J. Endocr. Soc."},{"key":"4411_CR27","doi-asserted-by":"crossref","unstructured":"A.A. Parsa, M.I. New, Steroid 21-hydroxylase deficiency in congenital adrenal hyperplasia. J Steroid Biochem Mol Biol, 2017. 165(Pt A): pp. 2\u201311","DOI":"10.1016\/j.jsbmb.2016.06.015"},{"issue":"2","key":"4411_CR28","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1530\/EJE-10-0877","volume":"164","author":"H Falhammar","year":"2011","unstructured":"H. Falhammar et al., Cardiovascular risk, metabolic profile, and body composition in adult males with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Eur. J. Endocrinol. 164(2), 285\u2013293 (2011)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"4411_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-10-0284","volume":"163","author":"I Nermoen","year":"2010","unstructured":"I. Nermoen et al., Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway. Eur. J. Endocrinol. 163(3), 453\u2013459 (2010)","journal-title":"Eur. J. Endocrinol."},{"issue":"11","key":"4411_CR30","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"W. Arlt et al., Health status of adults with congenital adrenal hyperplasia: A cohort study of 203 patients. J. Clin. Endocrinol. Metabolism. 95(11), 5110\u20135121 (2010)","journal-title":"J. Clin. Endocrinol. Metabolism"},{"issue":"2","key":"4411_CR31","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.ecl.2017.01.008","volume":"46","author":"F Hannah-Shmouni","year":"2017","unstructured":"F. Hannah-Shmouni, W. Chen, D.P. Merke, Genetics of congenital adrenal hyperplasia. Endocrinol. Metab. Clin. North. Am. 46(2), 435\u2013458 (2017)","journal-title":"Endocrinol. Metab. Clin. North. Am."},{"issue":"3","key":"4411_CR32","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1203\/PDR.0b013e3181b1bbec","volume":"66","author":"L Martinerie","year":"2009","unstructured":"L. Martinerie et al., Physiological partial aldosterone resistance in human newborns. Pediatr. Res. 66(3), 323\u2013328 (2009)","journal-title":"Pediatr. Res."},{"issue":"11","key":"4411_CR33","doi-asserted-by":"publisher","first-page":"4097","DOI":"10.1210\/jc.2018-01862","volume":"103","author":"S Tamhane","year":"2018","unstructured":"S. Tamhane et al., Cardiovascular and metabolic outcomes in congenital adrenal hyperplasia: A systematic review and Meta-Analysis. J. Clin. Endocrinol. Metab. 103(11), 4097\u20134103 (2018)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04411-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04411-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04411-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T18:02:54Z","timestamp":1765908174000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04411-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,3]]},"references-count":33,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4411"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04411-8","relation":{},"ISSN":["1559-0100"],"issn-type":[{"type":"electronic","value":"1559-0100"}],"subject":[],"published":{"date-parts":[[2025,9,3]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}